NeuroSigma to price IPO of 3,571,429 shares at $13.00-$15.00

Jefferies is the bookrunning manager; BTIG, Craig-Hallum assist

By Devika Patel

Knoxville, Tenn., Sept. 29 – NeuroSigma, Inc. will sell 3,571,429 common shares in its initial public offering with a 30-day greenshoe of 535,714 additional shares, according to a Form S-1/A filed Monday with the Securities and Exchange Commission. The deal was announced Aug. 26.

The shares will be sold at a price expected to fall between $13.00 and $15.00 per share.

Jefferies is the bookrunner. BTIG and Craig-Hallum Capital Group are the co-managers.

Proceeds will be used for research and development activities for EVK-001 and for working capital and other general corporate purposes.

The life sciences company is based in Los Angeles and focuses on developing bioelectronic products with the potential to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. The company expects its shares will trade on the Nasdaq under the symbol “NSIG.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.